News
Select Category
| All Entries | New Antibodies | Research News | About antibodies-online.com |
Disruption of the CFTR Gene Produces a Model of Cystic Fibrosis in Newborn Pigs
Area: Metabolism
A research group from the University of Iowa (USA) generated pigs in which both CFTR alleles were disrupted. Two decades ago CFTR was identified as the gene causing cystic fibrosis, however a cure to the disease has not been established yet.
In mouse models, the characteristic manifestations of human cystic fibrosis-like abnormalities of the pancreas, lung, intestine, liver could not be generated. Since pigs share many anatomical and physiological features with humans, they were chosen as model to target the CFTR gene.
Piglets without functional CFTR showed defective chloride transport and developed meconium ileus, exocrine pancreatic destruction, and focal biliary cirrhosis. Those abnormalities have also been observed in newborn humans with cystic fibrosis. The pig model may hence hold answers on the ultimate questions of cystic fibrosis pathogenesis and speed up the process of discovering strategies for prevention and treatment.
Related antibodies on antibodies-online.com:
Antibodies for the research area metabolism: »Show antibodies
-

09.02.2012 Conference: ICNBS Egypt 2012 -

02.02.2012 Heidelberg Forum for Young Life Scientists -

12.01.2012 BioChina International 2012 -

12.01.2012 Biomanufacturing Summit 2012 -

06.01.2012 2nd Annual International Conference on Advances in Biotechnology (BIOTECH 2012) -

16.12.2011 Conference: 2nd annual Clinical Trials in Oncology -

16.12.2011 Conference: 5th Annual CEE & CIS Clinical Trials Forum -

23.11.2011 BioPharma Asia Convention 2012 -

28.10.2011 2nd World Congress on Analytical and Bioanalytical Techniques -

27.10.2011 2nd Annual Clinical Trials in Oncology Conference -

27.10.2011 Conference: Data Management in Clinical Trials -

19.10.2011 International Conference on Ovarian Cancer Screening 2011 -

19.10.2011 Conference: Ensuring the high quality of your clinical data in an era of cost cutting -

06.10.2011 Conference: World Stem Cells & Regenerative Medicine Congress Asia 2011 -

15.09.2011 Conference: Vaccines and Biologics -

15.09.2011 BIT's 4th Annual International Congress of Antibody (ICA2012) -

30.08.2011 Biosimilars and Biobetters conference: Aligning business & science for success -

30.08.2011 Regenerative Medicine: Barriers to commercialisation online summit 2011 -

26.08.2011 World Antibody Focus 2011 -

26.08.2011 SMi’s 10th annual Clinical Trials in CNS conference -

28.07.2011 Cancer Research Global Summit -

22.07.2011 Conference: VacChina 2011 -

21.06.2011 Conference: Your gateway to the Rare Disease market in Asia -

21.06.2011 Conference: Accelerate your stem cell development to commercialization -

25.05.2011 Microscopy Conference 2011

